GENEVA, July 9 -- JANSSEN PHARMACEUTICA NV filed a patent application (US2025/061153) for “INHIBITORS OF INTERLEUKIN-23 RECEPTOR”. With publication no. WO/2026/147796, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 7/08
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....